News | Radiology Business | August 04, 2022

Enhancing oncology model aims to improve patient-centered care, lower health care costs, and address health equity as part of President Biden’s Cancer Moonshot

Enhancing oncology model aims to improve patient-centered care, lower health care costs, and address health equity as part of President Biden’s Cancer Moonshot

August 4, 2022 — The Biden Administration, through the U.S. Department of Health and Human Services and the Centers for Medicare & Medicaid Services (CMS), announced a new model aimed at improving cancer care for Medicare patients and lowering health care costs. CMS’ Center for Medicare and Medicaid Innovation (Innovation Center) designed the Enhancing Oncology Model (EOM) to test how to improve health care providers’ ability to deliver care centered around patients, consider patients’ unique needs, and deliver cancer care in a way that will generate the best possible patient outcomes. The model will focus on supporting and learning from cancer patients, caregivers, and cancer survivors, while addressing inequities and providing patients with treatments that address their unique needs. This new model supports President Joe Biden’s Unity Agenda and Cancer Moonshot initiative to improve the experience of people and their families living with and surviving cancer.

“No one should have to battle cancer without access to high quality, coordinated care,” said HHS Secretary Xavier Becerra. “With this new Innovation Center model for oncology care, we are delivering on President Biden’s call to action to mobilize every option to address cancer, and creating a system of care that supports all patients and their families. We will continue to do all we can to make access to this care equitable and end cancer as we know it.”

“There are stark inequities in the ability of people with cancer across race, gender, region, and income to access cancer screening, diagnostics, and treatment,” said CMS Administrator Chiquita Brooks-LaSure. “CMS is working to advance President Biden’s Cancer Moonshot goals by helping Medicare cancer patients better navigate a challenging and often overwhelming journey. The Enhancing Oncology Model will incentivize participating oncology practices – including those in rural and underserved areas – to improve the provision of high quality, coordinated care that addresses patients’ social needs and improves patient and caregiver support.”

The central goal of EOM is to better support patients and improve their care experience, advancing a key goal of the Cancer Moonshot Initiative. Oncology practices who participate in EOM can expect to provide patient-focused Enhanced Services, such as 24/7 access to a clinician, patient navigation services, a detailed care plan, and screenings for health-related social needs. Patients will also have an opportunity to share feedback on their overall cancer care experience and health outcomes. EOM aims to increase and improve communications among patients, oncologists, and care teams in-between appointments and enable patients to more easily reach their health care providers with questions.

In addition to requiring participants to screen for health-related social needs, EOM includes other design elements that help drive CMS’ commitment to advancing health equity, including:

  • Offering an additional payment to participating oncology practices that provide Enhanced Services to patients who qualify for both Medicare and Medicaid,
  • Requiring participating providers to report patient demographic data (e.g., race, ethnicity, language, gender identity), and
  • Requiring participating providers to develop plans showing how they will address health equity gaps in their patient population.

President Biden has reignited the Cancer Moonshot and set new national goals: if we work together, we can cut the death rate from cancer by at least 50% over the next 25 years, and improve the experience of people and their families living with and surviving cancer — and, by doing this and more, end cancer as we know it today.

Earlier this month, HHS announced first-year funding awards of $215 million in a five-year, $1.1 billion investment into three national programs to prevent and control cancer. In May, HHS announced the availability of $5 million for community health centers, funded by HHS’ Health Resources and Services Administration, to increase equitable access to life-saving cancer screenings.

A fact sheet on EOM is available at:  https://www.cms.gov/newsroom/fact-sheets/enhancing-oncology-model

For oncology practices interested in participating in EOM, the Request for Applications is available at: https://app.innovation.cms.gov/EOM.  All EOM applications must be submitted by 11:59 pm Eastern Daylight Time on September 30, 2022.

More information on the Enhancing Oncology Model is available at: https://innovation.cms.gov/innovation-models/enhancing-oncology-model.

Related Cancer Moonshot Content:   

CMS Proposes Physician Payment Rule to Expand Access to High-Quality Care 

Increased Access to Care and Reduced Treatment Delays Lead Priorities as Radiation Oncologists Meet with Members of Congress  

ACR Updates Lung Cancer Screening Resource Based on CMS Final Coverage Decision  

Related CMS Content:  

Radiation Oncologists Applaud Biden-Harris Administration's Renewed Commitment to Cancer Moonshot  

Racial/Ethnic Disparities Persist in Lung Cancer Screening Eligibility  

Primary Lung Cancers Detected by LDCT are at Lower Risk of Brain Metastases  

Physician and Patient Groups Call On CMS to Update Medicare Lung Cancer Screening Coverage  

USPSTF Expands Lung Cancer Screening Eligibility Thresholds   

Low-dose CT for Lung Cancer Screening: Benefit Outweighs Potential Harm  

Physician and Patient Groups Call On CMS to Update Medicare Lung Cancer Screening Coverage  


Related Content

News | Radiology Business

July 31, 2024 — The American Registry of Radiologic Technologists (ARRT) announced the three Registered Technologists (R ...

Time July 31, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Computed Tomography (CT) | By Melinda Taschetta-Millane

In the ever-evolving landscape of medical imaging, computed tomography (CT) stands out as a cornerstone technology ...

Time July 30, 2024
arrow
News | Breast Imaging

July 29, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced a ...

Time July 29, 2024
arrow
News | Artificial Intelligence

July 26, 2024 — GE HealthCare and Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company, announced a strategic ...

Time July 26, 2024
arrow
Feature | Mobile C-Arms | By Melinda Taschetta-Millane

Mobile C-arms continue to revolutionize medical imaging, offering versatility, mobility and real-time visualization ...

Time July 26, 2024
arrow
Videos | Information Technology

Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and ...

Time July 25, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | Digital Pathology

July 24, 2024 — Proscia, a developer of artificial intelligence (AI)-enabled digital pathology solutions for precision ...

Time July 24, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
Subscribe Now